595 related articles for article (PubMed ID: 20060354)
21. Diagnostic role of DOG1 and p63 immunohistochemistry in salivary gland carcinomas.
Abd Raboh NM; Hakim SA
Int J Clin Exp Pathol; 2015; 8(8):9214-22. PubMed ID: 26464669
[TBL] [Abstract][Full Text] [Related]
22. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.
Edwards PC; Bhuiya T; Kelsch RD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):613-9. PubMed ID: 15153875
[TBL] [Abstract][Full Text] [Related]
23. [Expression of drug resistance and metastasis related gene in adenoid cystic carcinoma and mucoepidermoid carcinoma].
Wang XF; Guo Y; Jia SS
Zhonghua Kou Qiang Yi Xue Za Zhi; 2007 Feb; 42(2):78-9. PubMed ID: 17462150
[TBL] [Abstract][Full Text] [Related]
24. Expression of fragile histidine triad (FHIT) and WW-domain oxidoreductase gene (WWOX) in nasopharyngeal carcinoma.
Chen X; Li P; Yang Z; Mo WN
Asian Pac J Cancer Prev; 2013; 14(1):165-71. PubMed ID: 23534718
[TBL] [Abstract][Full Text] [Related]
25. [Significance of nm23 expression in malignant carcinoma of salivary gland].
Jin H; Li J; Chen X
Zhonghua Kou Qiang Yi Xue Za Zhi; 1997 Nov; 32(6):341-3. PubMed ID: 11189305
[TBL] [Abstract][Full Text] [Related]
26. Roles of FHIT and WWOX fragile genes in cancer.
Iliopoulos D; Guler G; Han SY; Druck T; Ottey M; McCorkell KA; Huebner K
Cancer Lett; 2006 Jan; 232(1):27-36. PubMed ID: 16225988
[TBL] [Abstract][Full Text] [Related]
27. Common fragile genes and digestive tract cancers.
Kuroki T; Tajima Y; Furui J; Kanematsu T
Surg Today; 2006; 36(1):1-5. PubMed ID: 16378185
[TBL] [Abstract][Full Text] [Related]
28. The expression of FHIT in salivary carcinoma ex pleomorphic adenoma.
Kujan O; Tarakji B; Thakker N; Al Kheraif AA; Sloan P
Anticancer Res; 2012 Aug; 32(8):3147-52. PubMed ID: 22843886
[TBL] [Abstract][Full Text] [Related]
29. Components of DNA damage checkpoint pathway regulate UV exposure-dependent alterations of gene expression of FHIT and WWOX at chromosome fragile sites.
Ishii H; Mimori K; Inageta T; Murakumo Y; Vecchione A; Mori M; Furukawa Y
Mol Cancer Res; 2005 Mar; 3(3):130-8. PubMed ID: 15798093
[TBL] [Abstract][Full Text] [Related]
30. Morphological heterogeneity of oral salivary gland carcinomas: a clinicopathologic study of 41 cases with long term follow-up emphasizing the overlapping spectrum of adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma.
Schwarz S; Müller M; Ettl T; Stockmann P; Zenk J; Agaimy A
Int J Clin Exp Pathol; 2011 Apr; 4(4):336-48. PubMed ID: 21577319
[TBL] [Abstract][Full Text] [Related]
31. Prognostic implications of NUMB immunoreactivity in salivary gland carcinomas.
Maiorano E; Favia G; Pece S; Resta L; Maisonneuve P; Di Fiore PP; Capodiferro S; Urbani U; Viale G
Int J Immunopathol Pharmacol; 2007; 20(4):779-89. PubMed ID: 18179751
[TBL] [Abstract][Full Text] [Related]
32. Predictive value of FHIT, p27, and pERK1/ERK2 in salivary gland carcinomas: a retrospective study.
Fiedler M; Renner P; Schubert J; Weber F; Hartmann A; Iro H; Vielsmeier V; Bohr C; Gerken M; Reichert TE; Ettl T
Clin Oral Investig; 2019 Oct; 23(10):3801-3809. PubMed ID: 30673867
[TBL] [Abstract][Full Text] [Related]
33. Midkine expression in malignant salivary gland tumors and its role in tumor angiogenesis.
Ota T; Ota K; Jono H; Fujimori H; Ueda M; Shinriki S; Sueyoshi T; Shinohara M; Ando Y
Oral Oncol; 2010 Sep; 46(9):657-61. PubMed ID: 20637680
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of cyclin D1 and cortactin is primarily independent of gene amplification in salivary gland adenoid cystic carcinoma.
Greer RO; Said S; Shroyer KR; Marileila VG; Weed SA
Oral Oncol; 2007 Sep; 43(8):735-41. PubMed ID: 17113340
[TBL] [Abstract][Full Text] [Related]
35. Clinical implication of CD166 expression in salivary gland tumor.
Andisheh-Tadbir A; Ashraf MJ; Khademi B; Ahmadi S
Tumour Biol; 2015 Apr; 36(4):2793-9. PubMed ID: 25472586
[TBL] [Abstract][Full Text] [Related]
36. Homozygous deletion but not mutation of exons 5 and 8 of the fragile histidine triad (FHIT) gene is associated with features of differentiated thyroid carcinoma.
Yin DT; Wang L; Sun J; Yin F; Yan Q; Shen RL; Gao JX; He G
Ann Clin Lab Sci; 2010; 40(3):267-72. PubMed ID: 20689140
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic modulation of endogenous tumor suppressor expression in lung cancer xenografts suppresses tumorigenicity.
Cantor JP; Iliopoulos D; Rao AS; Druck T; Semba S; Han SY; McCorkell KA; Lakshman TV; Collins JE; Wachsberger P; Friedberg JS; Huebner K
Int J Cancer; 2007 Jan; 120(1):24-31. PubMed ID: 17019711
[TBL] [Abstract][Full Text] [Related]
38. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
[TBL] [Abstract][Full Text] [Related]
39. Analysis of the tumour suppressor genes, FHIT and WT-1, and the tumour rejection genes, BAGE, GAGE-1/2, HAGE, MAGE-1, and MAGE-3, in benign and malignant neoplasms of the salivary glands.
Nagel H; Laskawi R; Eiffert H; Schlott T
Mol Pathol; 2003 Aug; 56(4):226-31. PubMed ID: 12890744
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands.
Ahmadian M; Wistuba II; Fong KM; Behrens C; Kodagoda DR; Saboorian MH; Shay J; Tomlinson GE; Blum J; Minna JD; Gazdar AF
Cancer Res; 1997 Sep; 57(17):3664-8. PubMed ID: 9288768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
